F. Maloisel et al., PLATIN SALTS-INDUCED HEMOLYTIC-ANEMIA - CISPLATIN-INDUCED AND THE FIRST CASE OF CARBOPLATIN-INDUCED HEMOLYSIS, Anti-cancer drugs, 6(2), 1995, pp. 324-326
Anemia is a common side effect of cisplatin, especially after repeated
infusions. The primary mechanism is a myelosuppression caused by cisp
latin's interference with iron metabolism, resulting in a lower count
of red cell precursors. Some authors report a hemolytic anemia similar
to penicillin-induced anemia, in which hemolysis is caused by an anti
globulin antibody directed against red cell membrane-bound cisplatin.
The authors report two cases of cisplatin-induced anemia and suggest t
hat the immune-complex hypothesis is responsible for hemolysis. The fi
rst case of carboplatin-induced hemolysis is also reported. Mechanisms
of hemolysis and clinical practice are discussed.